ABBOTT LABORATORIES T.ABT

Primary Symbol: ABT

Healthcare Medical Devices

Abbott Laboratories is a global healthcare company. The Company is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. The Diagnostic Products segment is engaged in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment is involved in the worldwide sales of a broad line of adult and pediatric nutritional products. The Medical Devices segment includes the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation, and diabetes care products.

NYSE:ABT - Post by User

ABBOTT LABORATORIES

<< Previous

Bullboard Posts

Next >>

Post by NLMooseon May 17, 2023 2:39pm

162 Views

Post# 35453025

Christy Wyatt Made A Bad Deal

In spite Absolute Software experiencing a major improvement in their financial performance, the company is being sold to the Americans, notably Crosspoint Capital Partners.

With the company sold for $11.50 US or $15.52 Canadian per share, Christy Wyatt and Absolute Software Board of Directors made a terrible deal.

Its no wonder why David Kwan and TD Securities dramatically lowered the target price from $16.00 US per share to a mere $11.50 a share.

What was Christy Wyatt thinking in selling the company to Americans and risk being rejected from the Canadian Government due to security concerns, and not keep it in Canada.

Shame on Christy Wyatt and Absolute Software management.

<< Previous

Bullboard Posts

Next >>

Two micro-cap stocks with strong fundamentals